We use cookies to ensure that we give you the best experience on our website. By continuing to browse the site you are agreeing to our use of cookies. If you would like to know more please click here.

Latest News

Ubiquigent and Cyclofluidic enter into collaboration to build novel Ubiquitin system targeted libraries


Dundee, UK, 3rd June 2015: Ubiquigent Limited, a company specialising in ubiquitin cell-signalling system drug discovery capabilities and services, and Cyclofluidic Limited, a leading medicinal chemistry company based on an innovative integrated discovery technology platform, announced today they have entered into an agreement to develop novel targeted libraries that specifically target the ubiquitin system.

Posted by author Date 15/06/2015